DOCSLIB.ORG

Libro De Abstract

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Libro De Abstract SPECIAL THANKS EMPRESAS COLABORADORAS SEV VI R O L O G Í A Publicación Oficial de la Sociedad Española de Virología 13th Spanish National Congress Of Virology Madrid 2015 CONGRESO NACIONAL DE Volumen 18 Número 1/2015 EXTRAORDINARIO VIROLOGÍA . PUBLICACIÓN OFICIAL DE LA SOCIEDAD ESPAÑOLA DE VIROLOGÍA 13th Spanish National Congress Of Virology Madrid 2015 Del 7 al 10 de junio de 2015 Auditorio de la Fábrica Nacional de Moneda y Timbre Real Casa de la Moneda de Madrid Volumen 18 Madrid 2015 Número 1/2015 EXTRAORDINARIO Edición y Coordinación: M Angeles Muñoz-Fernández &M. Dolores García-Alonso Diseño y Maquetación: DM&VCH.events.S.L. Diseño Portada: M. Dolores García-Alonso Impresión: Fragma: Servicios de impresión digital en Madrid ISSN (versión digital): 2172-6523 SEV – Sociedad Española de Virología Centro de Biología Molecular “Severo Ochoa” C/ Nicolás Cabrera, 1 28049 Cantoblanco – Madrid [email protected] Página web del congreso: www.congresonacionalvirologia2015.com La responsabilidad del contenido de las colaboraciones publicadas corresponderá a sus autores, quienes autorizan la reproducción de sus artículos a la SEV exclusivamente para esta edición. La SEV no hace necesariamente suyas las opiniones o los criterios expresados por sus colaboradores. Virología. Publicación Oficial de la Sociedad Española de Virología XIII CONGRESO NACIONAL DE VIROLOGÍA B I E N V E N I D A El Comité Organizador del XIII Congreso Nacional de Virología (XIII CNV) tiene el placer de comunicaros que éste se celebrará en Madrid, del 7 al 10 de junio de 2015. En el XIII CNV participan conjuntamente la Sociedad Española de Virología (SEV) y la Sociedad Italiana de Virología (SIV), y estará abierto13th a Spanish la participación National de virólogos de Latinoamérica. La SEV, la SIV y el Comité Organizador os da la bienvenida.Congress Of Virology El Acto Inaugural del Congreso se celebrará en el Ateneo de Madrid el día 7 de Junio y laMadrid sede del2015 Congreso será el Ayre Gran Hotel Colón de Madrid y la Fábrica Nacional de Moneda y Timbre - Real Casa de la Moneda en las Sesiones de los días 8 al 10 de Junio. El Ayre Gran Hotel Colón y la Fábrica Nacional de Moneda y Timbre - Real Casa de la Moneda se ubican junto al famoso Parque del Retiro y el Palacio de Deportes. Los miembros del Comité Organizador y Científico hemos diseñado un Programa Científico atractivo, contando con la presencia de virólogos españoles y extranjeros de reconocido prestigio, cubriendo los diversos campos de la virología, básicos, aplicados, traslacional y clínicos en sus vertientes humana, animal y vegetal. También se muestra la interacción de la virología con otras áreas de la biología, la medicina, la nanotecnología, la informática, la química o la física. El programa científico ha buscado que estén representadas las distintas áreas de la virología y os sintáis identificados, de tal forma que participéis de forma activa y enviéis comunicaciones. Todos los asistentes podremos discutir sobre los avances, logros y retos en el estudio de los virus, para generar nuevas ideas y promover la investigación entre la comunidad de virólogos, en un Congreso que esperamos sea fructífero y distendido. Para que los jóvenes tengan una mayor presencia, se ha destinado una Sesión a presentaciones rápidas, no mas de tres minutos, las denominadas "flash presentations" en las que en breve tiempo, como si de un anuncio se tratara, deberéis defender y difundir el gran trabajo que estáis desarrollando. Agradecemos a los miembros del Comité Organizador y del Comité Científico del XIII Congreso Nacional de Virología su esfuerzo e ilusión en la preparación de este importante Evento, especialmente al personal del Hospital General Universitario Gregorio Marañón y de otras instituciones de Madrid por su ayuda con los temas locales. Hacemos extensivo nuestro agradecimiento al Presidente y a los miembros de la Junta Directiva de la Sociedad Española de Virología por el apoyo que nos han prestado desde el inicio de los preparativos. También agradecemos a todas las instituciones participantes y empresas colaboradoras en este XIII Congreso Nacional de la Sociedad Española de Virología como patrocinadores, ya que sin su apoyo hubiera sido imposible realizar este Evento tan importante para la virología. Finalmente, Madrid ofrece los atractivos turísticos de una moderna capital europea. Por lo tanto, sería una gran satisfacción para nosotros si marcarais estas fechas en vuestras agendas. Deseamos que todos disfrutéis de este Congreso. Un cordial saludo en nombre del Comité Organizador, Mª Angeles Muñoz-Fernández, Presidenta del Comité Organizador del XIII CNV Volumen 18 – Número 1/2015 - EXTRAORDINARIO XIII CONGRESO NACIONAL DE VIROLOGÍA W E L C O M E The Organizing Committee of the 13th National Virology Congress (CNV) are pleased to announce that the Congress will be held from 7th to 10th June, 2015 at the Ateneo de Madrid where the Opening Session will take place. Whereas the Scientific Sessions from 8th to 10th June will be held at the Fábrica Nacional de 13th Spanish National Moneda y Timbre - Real Casa de la Moneda, the building of which is located next toCongress the famous Of Virology Retiro Park and Palacio de los Deportes. The 13th CNV will have great pleasure to host the Italian Society for Virology (SIV) together with the Spanish Society for Virology (SEV). The participation of virologists from LatinMadrid America 2015 will be especially welcom. The SEV, the SIV and the Organizing Committee hope that you will enjoy the Congress in Madrid and exploit the opportunity to interact with your colleagues. The members of the Organizing and Scientific Committees have planned an attractive Scientific Programme with the presence of Spanish and foreign virologists of recognized prestige that will cover various fields of basic, applied, translational and clinical aspects of human, veterinary and plant virology. The programme will also cover the fruitful interactions of virology with other areas of biology, medicine, nanotechnology, computing, chemistry and physics. We hope that basic and clinical researchers working in any branch of virology will be interested in submitting abstracts and actively participating in this Congress. All together, we will be able to discuss current progress, achievements and challenges in the study of viruses with the aim of generating new ideas and promoting research among the community of virologists, in a Congress that we hope will be both a fruitful and relaxed. To make the participation for young researchers in the scientific sessions easy, short (3 minutes) "flash-presentation" sessions have been scheduled in the Scientific Programme. We would like to thank the Scientific and Organizing Committees of this 13th National Congress of Virology for the enthusiasm and effort in the preparation of this important event. We are especially grateful to the staff of the Hospital General Universitario Gregorio Marañón and other institutions of Madrid for their help with the local issues. We extend our thanks to the President and the Executive Board of the Spanish Society of Virology for the support to this Congress. Moreover, we gratefully acknowledge the sponsorship of several institutions and companies: the 13th CNV would have not been possible without their support. Moreover, we believe that Madrid will offer you all the tourist attractions of a modern European capital. Therefore, it would be great pleasure for us if you could mark these dates in your agenda With my best regards on behalf of the Organizing Committee, Mª Angeles Muñoz-Fernández Chairwoman of the Organizing Committee of the 13th CNV. Virología. Publicación Oficial de la Sociedad Española de Virología XIII CONGRESO NACIONAL DE VIROLOGÍA ABREVIATURAS TOPICS PS: SESIÓN PLENARIA (Invited plenary lecture) PS: PLENARY SESSION (Invited plenary lecture) P: CONFERENCIAS PLENARIAS P: PLENARY LECTURE OP: PRESENTACIONES ORALES (Invited paper) OP: ORAL PRESENTATIONS (Invited paper) CO: PRESENTACIONES ORALES CO: ORAL PRESENTATIONS 13th Spanish National PO: SESIÓN POSTERS PO: POSTERS SESSION Congress Of Virology ÍNDICE TABLE OF CONTENTSMadrid 2015 Páginas Pages COMITES 5 COMMITTEES 5 PROGRAMA-VERSIÓN REDUCIDA 13 PROGRAMME-REDUCED VERSION 13 PROGRAMA 19 PROGRAMME 19 ABSTRACT SESIONES PLENARIAS 31 ABSTRACT PLENARY SESSION 31 SESIÓN PLENARIA I: FRONTIERS IN VIROLOGY 33 (PI): FRONTIERS IN VIROLOGY 33 SESIÓN PLENARIA II: EMERGING VIRUSES 36 (PII): EMERGING VIRUSES 36 PRESENTACIÓN ORAL I: EMERGING VIRUSES 38 (OP I): EMERGING VIRUSES 38 SESIÓN PLENARIA III: HEPATITIS A, B AND C: BASIC, 40 (P III): HEPATITIS A, B AND C: BASIC, TRANSLATIONAL 40 TRANSLATIONAL AND CLINICAL RESEARCH AND CLINICAL RESEARCH SESIÓN PLENARIA IV: INNATE IMMUNITY 44 (P IV): INNATE IMMUNITY 44 PRESENTACIÓN ORAL II: INNATE IMMUNITY 44 (OP II): INNATE IMMUNITY 44 SESIÓN PLENARIA V: STRUCTURAL ANALYSIS OF VIRUS 47 (P V): STRUCTURAL ANALYSIS OF VIRUS AND 47 AND BIOTECHNOLOGY BIOTECHNOLOGY PRESENTACIÓN ORAL III: STRUCTURAL ANALYSIS OF 49 (OP III): STRUCTURAL ANALYSIS OF VIRUS AND 49 VIRUS AND BIOTECHNOLOGY BIOTECHNOLOGY SESIÓN PLENARIA VI: PLANT VIRUS 51 (P VI): PLANT VIRUS 51 SESIONES PARALELAS 55 PARALLEL SESSION 55 SESIÓN PARALELA I: EMERGING VIRUSES AND 55 PARALLEL SESSION I: EMERGING VIRUSES AND 55 VETERINARY (CO 9 – CO 16) VETERINARY (CO 9 – CO 16) SESIÓN PARALELA II: HIV (CO 17 – CO 24) 62 PARALLEL SESSION II: HIV (CO 17 – CO 24) 62 SESIÓN PARALELA III: PLANT VIRUS 70 PARALLEL SESSION III: PLANT VIRUS 70 (CO 25 – CO 32) (CO 25 – CO 32) SESIÓN PARALELA IV: ANIMAL
Load more

Recommended publications
  • Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones
    Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones Bliss M. Beernink*,1, Katerina L. Holan*,1, Ryan R. Lappe1, Steven A. Whitham1 1 Department of Plant Pathology and Microbiology, Iowa State University * These authors contributed equally Corresponding Author Abstract Steven A. Whitham [email protected] Agrobacterium-based inoculation approaches are widely used for introducing viral vectors into plant tissues. This study details a protocol for the injection of maize Citation seedlings near meristematic tissue with Agrobacterium carrying a viral vector. Beernink, B.M., Holan, K.L., Lappe, R.R., Recombinant foxtail mosaic virus (FoMV) clones engineered for gene silencing and Whitham, S.A. Direct Agroinoculation of Maize Seedlings by Injection with gene expression were used to optimize this method, and its use was expanded Recombinant Foxtail Mosaic Virus and to include a recombinant sugarcane mosaic virus (SCMV) engineered for gene Sugarcane Mosaic Virus Infectious Clones. J. Vis. Exp. (168), e62277, expression. Gene fragments or coding sequences of interest are inserted into a doi:10.3791/62277 (2021). modified, infectious viral genome that has been cloned into the binary T-DNA plasmid vector pCAMBIA1380. The resulting plasmid constructs are transformed into Date Published Agrobacterium tumefaciens strain GV3101. Maize seedlings as young as 4 days February 27, 2021 old can be injected near the coleoptilar node with bacteria resuspended in MgSO4 DOI
    [Show full text]
  • Recombinant and Chimeric Viruses
    Recombinant and chimeric viruses: Evaluation of risks associated with changes in tropism Ben P.H. Peeters Animal Sciences Group, Wageningen University and Research Centre, Division of Infectious Diseases, P.O. Box 65, 8200 AB Lelystad, The Netherlands. May 2005 This report represents the personal opinion of the author. The interpretation of the data presented in this report is the sole responsibility of the author and does not necessarily represent the opinion of COGEM or the Animal Sciences Group. Dit rapport is op persoonlijke titel door de auteur samengesteld. De interpretatie van de gepresenteerde gegevens komt geheel voor rekening van de auteur en representeert niet de mening van de COGEM, noch die van de Animal Sciences Group. Advisory Committee Prof. dr. R.C. Hoeben (Chairman) Leiden University Medical Centre Dr. D. van Zaane Wageningen University and Research Centre Dr. C. van Maanen Animal Health Service Drs. D. Louz Bureau Genetically Modified Organisms Ing. A.M.P van Beurden Commission on Genetic Modification Recombinant and chimeric viruses 2 INHOUDSOPGAVE RECOMBINANT AND CHIMERIC VIRUSES: EVALUATION OF RISKS ASSOCIATED WITH CHANGES IN TROPISM Executive summary............................................................................................................................... 5 Introduction............................................................................................................................................ 7 1. Genetic modification of viruses .................................................................................................9
    [Show full text]
  • (LRV1) Pathogenicity Factor
    Antiviral screening identifies adenosine analogs PNAS PLUS targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor F. Matthew Kuhlmanna,b, John I. Robinsona, Gregory R. Bluemlingc, Catherine Ronetd, Nicolas Faseld, and Stephen M. Beverleya,1 aDepartment of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110; bDepartment of Medicine, Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO 63110; cEmory Institute for Drug Development, Emory University, Atlanta, GA 30329; and dDepartment of Biochemistry, University of Lausanne, 1066 Lausanne, Switzerland Contributed by Stephen M. Beverley, December 19, 2016 (sent for review November 21, 2016; reviewed by Buddy Ullman and C. C. Wang) + + The endogenous double-stranded RNA (dsRNA) virus Leishmaniavirus macrophages infected in vitro with LRV1 L. guyanensis or LRV2 (LRV1) has been implicated as a pathogenicity factor for leishmaniasis Leishmania aethiopica release higher levels of cytokines, which are in rodent models and human disease, and associated with drug-treat- dependent on Toll-like receptor 3 (7, 10). Recently, methods for ment failures in Leishmania braziliensis and Leishmania guyanensis systematically eliminating LRV1 by RNA interference have been − infections. Thus, methods targeting LRV1 could have therapeutic ben- developed, enabling the generation of isogenic LRV1 lines and efit. Here we screened a panel of antivirals for parasite and LRV1 allowing the extension of the LRV1-dependent virulence paradigm inhibition, focusing on nucleoside analogs to capitalize on the highly to L. braziliensis (12). active salvage pathways of Leishmania, which are purine auxo- A key question is the relevancy of the studies carried out in trophs.
    [Show full text]
  • The Viruses of Wild Pigeon Droppings
    The Viruses of Wild Pigeon Droppings Tung Gia Phan1,2, Nguyen Phung Vo1,3,A´ kos Boros4,Pe´ter Pankovics4,Ga´bor Reuter4, Olive T. W. Li6, Chunling Wang5, Xutao Deng1, Leo L. M. Poon6, Eric Delwart1,2* 1 Blood Systems Research Institute, San Francisco, California, United States of America, 2 Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America, 3 Pharmacology Department, School of Pharmacy, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh, Vietnam, 4 Regional Laboratory of Virology, National Reference Laboratory of Gastroenteric Viruses, A´ NTSZ Regional Institute of State Public Health Service, Pe´cs, Hungary, 5 Stanford Genome Technology Center, Stanford, California, United States of America, 6 Centre of Influenza Research and School of Public Health, University of Hong Kong, Hong Kong SAR Abstract Birds are frequent sources of emerging human infectious diseases. Viral particles were enriched from the feces of 51 wild urban pigeons (Columba livia) from Hong Kong and Hungary, their nucleic acids randomly amplified and then sequenced. We identified sequences from known and novel species from the viral families Circoviridae, Parvoviridae, Picornaviridae, Reoviridae, Adenovirus, Astroviridae, and Caliciviridae (listed in decreasing number of reads), as well as plant and insect viruses likely originating from consumed food. The near full genome of a new species of a proposed parvovirus genus provisionally called Aviparvovirus contained an unusually long middle ORF showing weak similarity to an ORF of unknown function from a fowl adenovirus. Picornaviruses found in both Asia and Europe that are distantly related to the turkey megrivirus and contained a highly divergent 2A1 region were named mesiviruses.
    [Show full text]
  • Computational Exploration of Virus Diversity on Transcriptomic Datasets
    Computational Exploration of Virus Diversity on Transcriptomic Datasets Digitaler Anhang der Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Simon Käfer aus Andernach Bonn 2019 Table of Contents 1 Table of Contents 1 Preliminary Work - Phylogenetic Tree Reconstruction 3 1.1 Non-segmented RNA Viruses ........................... 3 1.2 Segmented RNA Viruses ............................. 4 1.3 Flavivirus-like Superfamily ............................ 5 1.4 Picornavirus-like Viruses ............................. 6 1.5 Togavirus-like Superfamily ............................ 7 1.6 Nidovirales-like Viruses .............................. 8 2 TRAVIS - True Positive Details 9 2.1 INSnfrTABRAAPEI-14 .............................. 9 2.2 INSnfrTADRAAPEI-16 .............................. 10 2.3 INSnfrTAIRAAPEI-21 ............................... 11 2.4 INSnfrTAORAAPEI-35 .............................. 13 2.5 INSnfrTATRAAPEI-43 .............................. 14 2.6 INSnfrTBERAAPEI-19 .............................. 15 2.7 INSytvTABRAAPEI-11 .............................. 16 2.8 INSytvTALRAAPEI-35 .............................. 17 2.9 INSytvTBORAAPEI-47 .............................. 18 2.10 INSswpTBBRAAPEI-21 .............................. 19 2.11 INSeqtTAHRAAPEI-88 .............................. 20 2.12 INShkeTCLRAAPEI-44 .............................. 22 2.13 INSeqtTBNRAAPEI-11 .............................. 23 2.14 INSeqtTCJRAAPEI-20
    [Show full text]
  • Viruses in Transplantation - Not Always Enemies
    Viruses in transplantation - not always enemies Virome and transplantation ECCMID 2018 - Madrid Prof. Laurent Kaiser Head Division of Infectious Diseases Laboratory of Virology Geneva Center for Emerging Viral Diseases University Hospital of Geneva ESCMID eLibrary © by author Conflict of interest None ESCMID eLibrary © by author The human virome: definition? Repertoire of viruses found on the surface of/inside any body fluid/tissue • Eukaryotic DNA and RNA viruses • Prokaryotic DNA and RNA viruses (phages) 25 • The “main” viral community (up to 10 bacteriophages in humans) Haynes M. 2011, Metagenomic of the human body • Endogenous viral elements integrated into host chromosomes (8% of the human genome) • NGS is shaping the definition Rascovan N et al. Annu Rev Microbiol 2016;70:125-41 Popgeorgiev N et al. Intervirology 2013;56:395-412 Norman JM et al. Cell 2015;160:447-60 ESCMID eLibraryFoxman EF et al. Nat Rev Microbiol 2011;9:254-64 © by author Viruses routinely known to cause diseases (non exhaustive) Upper resp./oropharyngeal HSV 1 Influenza CNS Mumps virus Rhinovirus JC virus RSV Eye Herpes viruses Parainfluenza HSV Measles Coronavirus Adenovirus LCM virus Cytomegalovirus Flaviviruses Rabies HHV6 Poliovirus Heart Lower respiratory HTLV-1 Coxsackie B virus Rhinoviruses Parainfluenza virus HIV Coronaviruses Respiratory syncytial virus Parainfluenza virus Adenovirus Respiratory syncytial virus Coronaviruses Gastro-intestinal Influenza virus type A and B Human Bocavirus 1 Adenovirus Hepatitis virus type A, B, C, D, E Those that cause
    [Show full text]
  • Mini Review Picobirnavirus: a Putative Emerging Threat to Humans And
    Advances in Animal and Veterinary Sciences Mini Review Picobirnavirus: A Putative Emerging Threat to Humans and Animals JOBIN JOSE KATTOOR, SHUBHANKAR SIRCAR, SHARAD SAURAB, SHANMUGANATHAN SUBRAMANIYAN, KULDEEP DHAMA, YASHPAL SINGH MALIK* ICAR-Indian Veterinary Research Institute, Izatnagar 243122, Bareilly, Uttar Pradesh, India. Abstract | Diarrheal diseases remain fatal threat to human and animal population with the emergence of new types of pathogens. Among them, viral gastroenteritis plays a lion share with a number ranging over 100 different types including emerging and re-emerging types of viruses. Recent viral metagenomics studies confirm the co-existence of viruses in gastrointestinal tract of several different host species. A Picobirnavirus, consisting of 2 segments, has recently attained attention due to its wide host range and genetic variability. Until 2011, these small viruses were not consid- ered as a separate virus family, when a new family (Picobirnaviridae) was approved by the International Committee on Taxonomy of Viruses (ICTV). Currently two distinct genogroups (GG-I and GG-II) and one predicted genogroup (GG-III) are included in the Picobirnaviridae family. Recently, picobirnavirus infections have been reported from al- most all species including wild animals where persistent infection of the virus is also reported. Picobirnaviruses (PBVs) are also reported as opportunistic pathogens in immuno compromised hosts including HIV infected patients. Presence of atypical picobirnaviruses with shorter genomic segments along with genetic closeness of animal and human PBVs and its ability to infect immuno-compromised hosts pose a heavy threat for all human and animal. Currently RNA dependent RNA polymerase based RT-PCR detection is considered as a rapid and sensitive method for detection of PBV.
    [Show full text]
  • First Insight Into the Viral Community of the Cnidarian Model Metaorganism Aiptasia Using RNA-Seq Data
    First insight into the viral community of the cnidarian model metaorganism Aiptasia using RNA-Seq data Jan D. Brüwer and Christian R. Voolstra Red Sea Research Center, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Makkah, Saudi Arabia ABSTRACT Current research posits that all multicellular organisms live in symbioses with asso- ciated microorganisms and form so-called metaorganisms or holobionts. Cnidarian metaorganisms are of specific interest given that stony corals provide the foundation of the globally threatened coral reef ecosystems. To gain first insight into viruses associated with the coral model system Aiptasia (sensu Exaiptasia pallida), we analyzed an existing RNA-Seq dataset of aposymbiotic, partially populated, and fully symbiotic Aiptasia CC7 anemones with Symbiodinium. Our approach included the selective removal of anemone host and algal endosymbiont sequences and subsequent microbial sequence annotation. Of a total of 297 million raw sequence reads, 8.6 million (∼3%) remained after host and endosymbiont sequence removal. Of these, 3,293 sequences could be assigned as of viral origin. Taxonomic annotation of these sequences suggests that Aiptasia is associated with a diverse viral community, comprising 116 viral taxa covering 40 families. The viral assemblage was dominated by viruses from the families Herpesviridae (12.00%), Partitiviridae (9.93%), and Picornaviridae (9.87%). Despite an overall stable viral assemblage, we found that some viral taxa exhibited significant changes in their relative abundance when Aiptasia engaged in a symbiotic relationship with Symbiodinium. Elucidation of viral taxa consistently present across all conditions revealed a core virome of 15 viral taxa from 11 viral families, encompassing many viruses previously reported as members of coral viromes.
    [Show full text]
  • Western Equine Encephalitis Virus Is a Recombinant Virus (RNA Recombination/Alphavirus/Evolution of RNA Viruses) CHANG S
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 5997-6001, August 1988 Evolution Western equine encephalitis virus is a recombinant virus (RNA recombination/Alphavirus/evolution of RNA viruses) CHANG S. HAHN, SHLOMO LUSTIG*, ELLEN G. STRAUSS, AND JAMES H. STRAUSSt Division of Biology, 156-29, California Institute of Technology, Pasadena, CA 91125 Communicated by James Bonner, April 14, 1988 ABSTRACT The alphaviruses are a group of 26 mosquito- virus; O'Nyong-nyong virus; and Ross River virus. Sindbis borne viruses that cause a variety of human diseases. Many of and Semliki Forest viruses have been intensively studied as the New World alphaviruses cause encephalitis, whereas the models for alphavirus replication (7). Sindbis virus is widely Old World viruses more typically cause fever, rash, and distributed, being found in Europe, India, southeast Asia, arthralgia. The genome is a single-stranded nonsegmented Australia, and Africa. Close relatives of this virus, such as RNA molecule of + polarity; it is about 11,700 nucleotides in Ockelbo virus in Europe (8) and Babanki virus in Africa, length. Several alphavirus genomes have been sequenced in cause disease in humans characterized by fever, rash, and whole or in part, and these sequences demonstrate that alpha- arthritis. Chikungunya and O'Nyong-nyong viruses have viruses have descended from a common ancestor by divergent caused large epidemics in Africa of a dengue-like disease also evolution. We have now obtained the sequence of the 3'- characterized by fever, rash, and arthralgia. Ross River virus terminal 4288 nucleotides of the RNA of the New World is the causative agent of epidemic polyarthritis in Australia Alphavirus western equine encephalitis virus (WEEV).
    [Show full text]
  • Recombinant Influenza H9N2 Virus with a Substitution of H3
    www.nature.com/scientificreports OPEN Recombinant infuenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane Received: 4 September 2017 Accepted: 30 November 2017 domain showed enhanced Published: xx xx xxxx immunogenicity in mice and chicken Yun Zhang , Ying Wei, Kang Liu, Mengjiao Huang, Ran Li, Yang Wang, Qiliang Liu, Jing Zheng, Chunyi Xue & Yongchang Cao In recent years, avian infuenza virus H9N2 undergoing antigenic drift represents a threat to poultry farming as well as public health. Current vaccines are restricted to inactivated vaccine strains and their related variants. In this study, a recombinant H9N2 (H9N2-TM) strain with a replaced H3 hemagglutinin (HA) transmembrane (TM) domain was generated. Virus assembly and viral protein composition were not afected by the transmembrane domain replacement. Further, the recombinant TM-replaced H9N2-TM virus could provide better inter-clade protection in both mice and chickens against H9N2, suggesting that the H3-TM-replacement could be considered as a strategy to develop efcient subtype- specifc H9N2 infuenza vaccines. H9N2 avian infuenza virus was frst isolated in turkeys in 19661. Since then, it became prevalent in poultry farming worldwide, resulting in egg production reduction and high mortality when co-infected with other path- ogens2,3. Also, it could cross host-species barrier and cause human infections as reported in China4,5. Tough it is not highly pathogenic as H5N1, researches revealed that it could re-assort with multiple other infuenza subtypes and thus be “gene donor” for H5N1 and H7N9 viruses6–8. Terefore, control of the H9N2 infuenza virus is of great concern. Vaccination utilizing vaccine strains and their relevant variants is the main strategy to control H9N2 pan- demics in the poultry industry of China.
    [Show full text]
  • Discrimination and Trancriptional Response
    DISCRIMINATION AND TRANCRIPTIONAL RESPONSE ANALYSIS OF HEMIPTERAN PHYTOPATHOGEN VECTORS By SHARON ANDREASON Bachelor of Science in Biology University of Texas at Tyler Tyler, Texas 2009 Submitted to the Faculty of the Graduate College of the Oklahoma State University in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY July, 2016 DISCRIMINATION AND TRANSCRIPTIONAL RESPONSE ANALYSIS OF HEMIPTERAN PHYTOPATHOGEN VECTORS Dissertation Approved: Astri Wayadande, Ph.D. Dissertation Adviser Jacqueline Fletcher, Ph.D. Francisco Ochoa-Corona, Ph.D. Ulrich Melcher, Ph.D. ii ACKNOWLEDGEMENTS I would first like to extend my deepest thanks to my advisor, Dr. Astri Wayadande, for all of her years of support. Always full of positivity, encouragement, and advice, her enthusiasm for research and effort devoted to others are attributes that I aspire to cultivate in my future career. I am forever grateful for her guidance throughout earning my degree. I would also like to thank my committee members, Drs. Jacqueline Fletcher, Francisco Ochoa-Corona, and Ulrich Melcher, each of whom have not only offered me thoughtful advice through my research, but have also educated and inspired me in unique and invaluable ways. I am deeply appreciative of their guidance over the years. I want to thank Dr. Judith Brown, without whom I would not have had the opportunity to work on such an important vector system. I am sincerely grateful to Dr. Mohammad Arif, who provided exceptional expertise and advice through my whitefly projects. I would also like to extend my thanks to Dr. Trenna Blagden for all her help and guidance on my projects, particularly during my work with EDNA, as well as for the professional advice she has provided.
    [Show full text]
  • Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic: a Repo
    Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada. November 2020 update This evidence synthesis was prepared for the Office of the Chief Dental Officer, based on a comprehensive review under contract by the following: Paul Allison, Faculty of Dentistry, McGill University Raphael Freitas de Souza, Faculty of Dentistry, McGill University Lilian Aboud, Faculty of Dentistry, McGill University Martin Morris, Library, McGill University November 30th, 2020 1 Contents Page Introduction 3 Project goal and specific objectives 3 Methods used to identify and include relevant literature 4 Report structure 5 Summary of update report 5 Report results a) Which patients are at greater risk of the consequences of COVID-19 and so 7 consideration should be given to delaying elective in-person oral health care? b) What are the signs and symptoms of COVID-19 that oral health professionals 9 should screen for prior to providing in-person health care? c) What evidence exists to support patient scheduling, waiting and other non- treatment management measures for in-person oral health care? 10 d) What evidence exists to support the use of various forms of personal protective equipment (PPE) while providing in-person oral health care? 13 e) What evidence exists to support the decontamination and re-use of PPE? 15 f) What evidence exists concerning the provision of aerosol-generating 16 procedures (AGP) as part of in-person
    [Show full text]